advertisement

Oculus

3.9 Pathophysiology (113)

Showing records 1 to 25

Display all abstracts in classification 3.9 Pathophysiology

Search within classification 3.9 Pathophysiology
90868 Inflammation in Glaucoma: From the back to the front of the eye, and beyond
Baudouin C
Progress in Retinal and Eye Research 2020; 0: 100916
91020 Improvement in structure and visual function in patients with glaucoma: the possible key to better treatment?
Ahmed OM
Survey of Ophthalmology 2020; 0:
91055 Investigation of associations between Piezo1 mechanoreceptor gain-of-function variants and glaucoma-related phenotypes in humans and mice
Baxter SL
Scientific reports 2020; 10: 19013
90902 Intraocular pressure reduction in glaucoma: Does every mmHg count?
Jayaram H
Taiwan journal of ophthalmology 2020; 10: 255-258
91615 Cathepsin B Localizes in the Caveolae and Participates in the Proteolytic Cascade in Trabecular Meshwork Cells. Potential New Drug Target for the Treatment of Glaucoma
Nettesheim A
Journal of clinical medicine 2020; 10:
91224 Disruption of 24-Hour Rhythm in Intraocular Pressure Correlates with Retinal Ganglion Cell Loss in Glaucoma
Neroev V
International journal of molecular sciences 2020; 22:
91291 Pathophysiology of the comorbidity of glaucoma with obstructive sleep apnea: A postulation
Goyal M
European Journal of Ophthalmology 2021; 0: 1120672121990580
91766 Tryptophan Pathway Abnormalities in a Murine Model of Hereditary Glaucoma
Fiedorowicz M
International journal of molecular sciences 2021; 22:
91385 TET-dependent GDF7 hypomethylation impairs aqueous humor outflow and serves as a potential therapeutic target in glaucoma
Wan P
Molecular Therapy 2021; 29: 1639-1657
91803 GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension
Sterling JK
Cell reports 2020; 33: 108271
91263 Association of vitamin D with incident glaucoma: findings from the Women's Health Initiative
Carbone LD
Journal of Investigative Medicine 2021; 0:
91164 The loss of microglia activities facilitates glaucoma progression in association with CYP1B1 gene mutation (p.Gly61Glu)
Alghamdi A
PLoS ONE 2020; 15: e0241902
91694 Roles of the ocular pressure, pressure-sensitive ion channel, and elasticity in pressure-induced retinal diseases
Pang JJ
Neural Regeneration Research 2021; 16: 68-72
91134 Biomineralization of Trabecular Meshwork in Open-Angle Glaucoma
Kravchik MV
Doklady. Biochemistry and biophysics 2020; 495: 307-310
91741 Loss of the Extracellular Matrix Molecule Tenascin-C Leads to Absence of Reactive Gliosis and Promotes Anti-inflammatory Cytokine Expression in an Autoimmune Glaucoma Mouse Model
Wiemann S
Frontiers in immunology 2020; 11: 566279
91763 Can Polyphenols in Eye Drops Be Useful for Trabecular Protection from Oxidative Damage?
Saccà SC
Journal of clinical medicine 2020; 9:
91257 Systemic inflammation in both open-angle and angle-closure glaucoma: role of platelet-to-lymphocyte ratio
Karahan M
Bratisl Lek Listy 2021; 122: 45-48
91135 Potential roles of astrocytes and Müller cells in the pathogenesis of glaucoma
Shinozaki Y
Journal of Pharmacological Sciences 2021; 145: 262-267
91696 Retinal oxidative stress activates the NRF2/ARE pathway: An early endogenous protective response to ocular hypertension
Naguib S
Redox biology 2021; 0: 101883
91649 Complement peptide C3a receptor 1 promotes optic nerve degeneration in DBA/2J mice
Williams PA
Journal of Neuroinflammation 2020; 17: 336
91615 Cathepsin B Localizes in the Caveolae and Participates in the Proteolytic Cascade in Trabecular Meshwork Cells. Potential New Drug Target for the Treatment of Glaucoma
Shim MS
Journal of clinical medicine 2020; 10:
91134 Biomineralization of Trabecular Meshwork in Open-Angle Glaucoma
Subbot AM
Doklady. Biochemistry and biophysics 2020; 495: 307-310
91020 Improvement in structure and visual function in patients with glaucoma: the possible key to better treatment?
Waisbourd M
Survey of Ophthalmology 2020; 0:
91263 Association of vitamin D with incident glaucoma: findings from the Women's Health Initiative
Johnson K
Journal of Investigative Medicine 2021; 0:
91803 GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension
Adetunji MO
Cell reports 2020; 33: 108271

Issue 21-4

Change Issue


advertisement

Oculus